Literature DB >> 25284511

Identification and characterization of 5'-flanking region of the human riboflavin transporter 1 gene (SLC52A1).

Subrata Sabui1, Abhisek Ghosal1, Hamid M Said2.   

Abstract

The human SLC52A1 gene encodes the riboflavin transporter-1 (RFVT-1), a plasma membrane protein that transports vitamin B2 (riboflavin, RF) into cells, and thus, plays a role in controlling cellular homeostasis of RF in those tissues that express the carrier protein (e.g. placenta and intestine). Currently, there is nothing known about transcriptional regulation of the SLC52A1 gene, therefore, we aimed to clone and characterize its 5'-flanking region. Using rapid amplification of the cDNA ends (5'-RACE), we identified one transcription start site (TSS). A 579 bp segment of the 5'-flanking region of this gene was cloned which exhibited robust promoter activity upon transfection in human intestinal epithelial cells. Deletion analysis revealed that the core promoter activity to be embedded in a region between -234 and -23 that lacked TATA element, was GC-rich, and harbored several putative cis-regulatory sites including KLFs, AP-2, EGRF and Sp-1. Mutating each of these sites led to a significant decrease in promoter activity (which was highest for the Sp-1 site), suggesting their possible involvement in regulating SLC52A1 transcription. Focusing on the Sp-1 site, EMSA, super-shift and ChIP analysis was performed that established the interaction of the Sp-1 transcription factor with the SLC52A1 promoter; also, co-transfection of the minimal SLC52A1 promoter with an Sp-1 containing vector in Drosophila SL-2 cells led to significant promoter activation. These results are the first to reveal the identity of the minimal SLC52A1 promoter and to establish an important role for Sp-1 in its activity.
Copyright © 2014. Published by Elsevier B.V.

Entities:  

Keywords:  Minimal promoter; Riboflavin transporter; SLC52A1; Transcription regulation

Mesh:

Substances:

Year:  2014        PMID: 25284511      PMCID: PMC4254174          DOI: 10.1016/j.gene.2014.10.001

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  41 in total

Review 1.  Recent advances in carrier-mediated intestinal absorption of water-soluble vitamins.

Authors:  Hamid M Said
Journal:  Annu Rev Physiol       Date:  2004       Impact factor: 19.318

Review 2.  Intestinal absorption of water-soluble vitamins in health and disease.

Authors:  Hamid M Said
Journal:  Biochem J       Date:  2011-08-01       Impact factor: 3.857

3.  Protection by vitamin B2 against oxidant-mediated acute lung injury.

Authors:  A Seekamp; D E Hultquist; G O Till
Journal:  Inflammation       Date:  1999-10       Impact factor: 4.092

4.  [Metabolism of riboflavin and B group vitamins functionally bound to it in insulin-dependent diabetes mellitus].

Authors:  V M Kodentsova; O A Vrzhesinskaia; A A Sokol'nikov; I A Alekseeva; V B Spirichev
Journal:  Vopr Med Khim       Date:  1993 Sep-Oct

5.  Novel mutations in ETFDH gene in Chinese patients with riboflavin-responsive multiple acyl-CoA dehydrogenase deficiency.

Authors:  Lap-Kay Law; Nelson L S Tang; Joannie Hui; Simon L M Fung; Jos Ruiter; Ronald J A Wanders; Tai-Fai Fok; Christopher W K Lam
Journal:  Clin Chim Acta       Date:  2009-03-03       Impact factor: 3.786

6.  Riboflavin-mediated reduction of oxidant injury, rejection, and vasculopathy after cardiac allotransplantation.

Authors:  Koichiro Iwanaga; Tomomi Hasegawa; Donald E Hultquist; Hiroaki Harada; Yasushi Yoshikawa; Sunitha Yanamadala; Hui Liao; Scott H Visovatti; David J Pinsky
Journal:  Transplantation       Date:  2007-03-27       Impact factor: 4.939

7.  Uptake of riboflavin by intestinal basolateral membrane vesicles: a specialized carrier-mediated process.

Authors:  H M Said; D Hollander; R Mohammadkhani
Journal:  Biochim Biophys Acta       Date:  1993-06-05

8.  In vitro and in vivo characterization of the minimal promoter region of the human thiamin transporter SLC19A2.

Authors:  Jack C Reidling; Hamid M Said
Journal:  Am J Physiol Cell Physiol       Date:  2003-09       Impact factor: 4.249

9.  Brown-Vialetto-Van Laere syndrome, a ponto-bulbar palsy with deafness, is caused by mutations in c20orf54.

Authors:  Peter Green; Matthew Wiseman; Yanick J Crow; Henry Houlden; Shelley Riphagen; Jean-Pierre Lin; F Lucy Raymond; Anne-Marie Childs; Eamonn Sheridan; Sian Edwards; Dragana J Josifova
Journal:  Am J Hum Genet       Date:  2010-03-04       Impact factor: 11.025

10.  Treatable childhood neuronopathy caused by mutations in riboflavin transporter RFVT2.

Authors:  A Reghan Foley; Manoj P Menezes; Amelie Pandraud; Michael A Gonzalez; Ahmad Al-Odaib; Alexander J Abrams; Kumiko Sugano; Atsushi Yonezawa; Adnan Y Manzur; Joshua Burns; Imelda Hughes; B Gary McCullagh; Heinz Jungbluth; Ming J Lim; Jean-Pierre Lin; Andre Megarbane; J Andoni Urtizberea; Ayaz H Shah; Jayne Antony; Richard Webster; Alexander Broomfield; Joanne Ng; Ann A Mathew; James J O'Byrne; Eva Forman; Mariacristina Scoto; Manish Prasad; Katherine O'Brien; Simon Olpin; Marcus Oppenheim; Iain Hargreaves; John M Land; Min X Wang; Kevin Carpenter; Rita Horvath; Volker Straub; Monkol Lek; Wendy Gold; Michael O Farrell; Sebastian Brandner; Rahul Phadke; Kazuo Matsubara; Michael L McGarvey; Steven S Scherer; Peter S Baxter; Mary D King; Peter Clayton; Shamima Rahman; Mary M Reilly; Robert A Ouvrier; John Christodoulou; Stephan Züchner; Francesco Muntoni; Henry Houlden
Journal:  Brain       Date:  2013-11-19       Impact factor: 13.501

View more
  3 in total

1.  Role of MicroRNA-423-5p in posttranscriptional regulation of the intestinal riboflavin transporter-3.

Authors:  Ram Lakhan; Veedamali S Subramanian; Hamid M Said
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2017-09-14       Impact factor: 4.052

2.  Effect of the proinflammatory cytokine TNF-α on intestinal riboflavin uptake: inhibition mediated via transcriptional mechanism(s).

Authors:  Kasin Yadunandam Anandam; Omar A Alwan; Veedamali S Subramanian; Padmanabhan Srinivasan; Rubina Kapadia; Hamid M Said
Journal:  Am J Physiol Cell Physiol       Date:  2018-08-29       Impact factor: 4.249

Review 3.  Development of Novel Experimental Models to Study Flavoproteome Alterations in Human Neuromuscular Diseases: The Effect of Rf Therapy.

Authors:  Maria Tolomeo; Alessia Nisco; Piero Leone; Maria Barile
Journal:  Int J Mol Sci       Date:  2020-07-26       Impact factor: 5.923

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.